Browsing 2016 by Synopsis "Clarifies that product approval from U.S. Food and Drug Administration is not required for drug manufacturer to file registration statement, and specifies timeframe by which DOH must review registration statements."

DSpace Repository

Home
Law
NEW JERSEY LEGISLATIVE HISTORIES
2016
Browsing 2016 by Synopsis

Digital Jerseyana Collection | New Jersey State Publications Digital Library | About NJ Digital Collections

Browsing 2016 by Synopsis "Clarifies that product approval from U.S. Food and Drug Administration is not required for drug manufacturer to file registration statement, and specifies timeframe by which DOH must review registration statements."

Now showing items 1-1 of 1

Clarifies that product approval from U.S. Food and Drug Administration is not required for drug manufacturer to file registration statement, and specifies timeframe by which DOH must review registration statements.

Compiled by the New Jersey State Library
Year: 2016; Chapter: 73

Now showing items 1-1 of 1

Search DSpace

Advanced Search

Browse

All
This Collection
- By Issue Date
- Authors
- Titles
- Subjects
- By Year
- By Chapter
- By Bill Number
- By Synopsis